Directed differentiation and characterization of genetically modified embryonic stem cells for therapy.

Adeline A. Lau, Kim M. Hemsley, Adrian Meedeniya, Aaron J. Robinson, John J. Hopwood

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Lysosomal storage disorders are rare, inherited diseases caused by a deficiency of a specific, lysosomal enzyme. In the case of mucopolysaccharidosis type IIIA, a lack of active sulfamidase enzyme results in heparan sulfate accumulation, severe and progressive neurological deficits, and usually premature death. Embryonic stem cells can be genetically modified to overexpress lysosomal enzymes, providing a renewable reservoir of cells that can be readily expanded in culture. Screening clonal lines of embryonic stem cells for desirable properties such as high levels and maintenance of enzyme activity throughout terminal differentiation to neural phenotypes theoretically provides a reproducible population of cells that can be fully characterized in vitro before implantation within the central nervous system in animal models of lysosomal storage disorders.

Original languageEnglish
Title of host publicationEmbryonic Stem Cell Protocols
EditorsKursad Turksen
PublisherHumana Press Inc.
Chapter32
Pages471-484
Number of pages14
Volume1
Edition2nd
ISBN (Electronic)9781597450379
ISBN (Print)9781588294982
DOIs
Publication statusPublished - 2006
Externally publishedYes

Publication series

NameMethods in Molecular Biology
Volume329
ISSN (Print)1064-3745

Keywords

  • clonal
  • differentiation
  • embryonic stem cells
  • in vitro
  • lysosomal enzyme
  • lysosomal storage disease
  • therapy
  • transgenic

Fingerprint Dive into the research topics of 'Directed differentiation and characterization of genetically modified embryonic stem cells for therapy.'. Together they form a unique fingerprint.

  • Cite this

    Lau, A. A., Hemsley, K. M., Meedeniya, A., Robinson, A. J., & Hopwood, J. J. (2006). Directed differentiation and characterization of genetically modified embryonic stem cells for therapy. In K. Turksen (Ed.), Embryonic Stem Cell Protocols (2nd ed., Vol. 1, pp. 471-484). (Methods in Molecular Biology; Vol. 329). Humana Press Inc.. https://doi.org/10.1385/1-59745-037-5:471